Based on our previous work in chronic myeloid leukaemia,21 we first analysed miR-17∼92 expression in ALL and observed a significantly lower expression in ALL as compared to normal CD34+ cells with further reduction in BCR-ABL-positive as compared to -negative ALL cells. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.